在阿尔茨海默病及其前中,炎症性细胞因子和认知
Su Jeong Seong1, Ki Woong Kim2,3,4, Joo Yun Song1
1Department of Psychiatry, Kangdong Sacred Heart Hospital, Seoul, Republic of Korea.
Psychiatry investigation
|October 28, 2024
概括
瘤亡因子-α (TNF-α) 的升高与老年人记忆力较差有关,即使考虑到年龄. 这表明炎症在认知衰退和记忆障碍中起着作用.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 老年学是一门学科.
背景情况:
- 认知障碍在老年人群中越来越令人担忧.
- 像TNF-α和IL-6这样的炎症标志物与神经退行过程有关.
研究的目的:
- 调查TNF-α和IL-6在血液中的水平与老年人的认知功能之间的关系.
- 确定这些炎症标志物是否与阿尔茨海默病和轻度认知障碍等认知障碍有关.
主要方法:
- 在老年参与者中测量TNF-α和IL-6的外周度.
- 使用CERAD神经心理评估电池 (CERAD-NP) 评估认知功能.
- 分析了细胞因子水平和认知测试得分 (z-scores) 之间的相关性.
主要成果:
- 患有阿尔茨海默氏病 (AD) 的参与者显示TNF-α和IL-6水平高于健康对照组.
- 较高的血IL-6与命名,单词学习,识别和结构性回忆等较低的分数相关.
- 较高的血清TNF-α与较低的单词学习和结构性回忆得分相关,即使在年龄调整后,这一发现也很重要.
结论:
- 虽然TNF-α和IL-6的群体差异可能与衰老有关,但TNF-α的升高与直接记忆障碍特别相关.
- 这些发现强调了特定的炎症途径和老年人的记忆力缺陷之间的潜在联系.
相关概念视频
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
101
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
101
Role of Neurotransmitters in Memory
456
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
456
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
Psychoneuroimmunology: Diabetes and Cancer
24
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
24


